Opioids for chronic non‐cancer neuropathic pain. An updated systematic review and meta‐analysis of efficacy, tolerability and safety in randomized placebo‐controlled studies of at least 4 weeks duration

Measures That Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: ACTTION Critique and Recommended Considerations

(2017) Shannon M. Smith et al.   JOURNAL OF PAIN

Cebranopadol, a novel first-in-class analgesic drug candidate

(2017) Annette Christoph et al.   PAIN

Stratifying patients with peripheral neuropathic pain based on sensory profiles

(2017) Jan Vollert et al.   PAIN

Transdermal Buprenorphine Relieves Neuropathic Pain: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial in Diabetic Peripheral Neuropathic Pain

(2016) Richard W. Simpson et al.   DIABETES CARE

CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016

(2016) Deborah Dowell et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Opioid use for the management of chronic non-cancer pain: French guidelines

(2016) X. Moisset et al.   REVUE NEUROLOGIQUE

Prevalence of Chronic Disabling Noncancer Pain and Associated Demographic and Medical Variables

(2015) Winfried Häuser et al.   CLINICAL JOURNAL OF PAIN

Two placebo-controlled, randomized withdrawal studies to evaluate the fentanyl 1 day patch in opioid-naïve patients with chronic pain

(2015) Tsutomu Arai et al.   CURRENT MEDICAL RESEARCH AND OPINION

Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic Review

(2015) Shannon M. Smith et al.   JOURNAL OF PAIN

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

(2015) Nanna B Finnerup et al.   LANCET NEUROLOGY

A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy

(2014) Aaron I. Vinik et al.   DIABETES CARE

Opioide bei chronischem neuropathischem Schmerz

(2014) C. Sommer et al.   SCHMERZ

Opioide bei chronischen nicht-tumorbedingten Schmerzen – sind sie Nichtopioidanalgetika überlegen?

(2014) P. Welsch et al.   SCHMERZ

Challenges in design and interpretation of chronic pain trials

(2013) R.A. Moore et al.   BRITISH JOURNAL OF ANAESTHESIA

Neuropathic pain in the general population: A systematic review of epidemiological studies

(2013) O. van Hecke et al.   PAIN

Don’t middle your MIDs: regression to the mean shrinks estimates of minimally important differences

(2013) Peter M. Fayers et al.   QUALITY OF LIFE RESEARCH

Randomized controlled trial of the combined monoaminergic and opioid investigational compound GRT9906 in painful polyneuropathy

(2011) S.H. Sindrup et al.   EUROPEAN JOURNAL OF PAIN

Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial

(2010) Sherwyn Schwartz et al.   CURRENT MEDICAL RESEARCH AND OPINION

Complex Regional Pain Syndrome Type I: Neuropathic or Not?

(2010) Dennis Naleschinski et al.   Current Pain and Headache Reports

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

(2010) N. Attal et al.   EUROPEAN JOURNAL OF NEUROLOGY

“Evidence” in chronic pain – establishing best practice in the reporting of systematic reviews

(2010) Andrew R. Moore et al.   PAIN

Morphine versus Mexiletine for Treatment of Postamputation Pain

(2009) Christopher L. Wu et al.   ANESTHESIOLOGY

Tramadol in Neuropathic Pain After Spinal Cord Injury

(2009) Cecilia Norrbrink et al.   CLINICAL JOURNAL OF PAIN